CoChat

Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies

H. Parikh, Rajesh, J. Patel, Ravish · 2016 · Current Drug Delivery

The DOI matches its Crossref record.

Abstract

Background Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease (MND), is a progressive neurodegenerative disorder characterized by the deterioration of both upper and lower motor neurons. Only one drug (riluzole) has been approved for the treatment of ALS. Riluzole is a BCS class II drug having 60% absolute bioavailability. It is a substrate of P-glycoprotein and BBB restricts its entry in brain. Objective This investigation was aimed to develop O/W nanoemulsion system of riluzole to improve its brain bioavailability. Methods Riluzole loaded nanoemulsion was prepared by phase titration method. It was consisting of 3% w/w Sefsol 218, 28.3% w/w Tween 80:Carbitol (1:1) and 68.7% w/w water. It was characterized for drop size, drop size distribution, transmittance, viscosity, pH, zeta potential, conductivity and nasal ciliotoxicity study. Thermodynamic stability and room temperature stability of prepared nanoemulsion formulation were evaluated. Pharmacokinetic and brain uptake study was carried out using albino rats (wistar) post intranasal and oral administration. Results Riluzole loaded nanoemulsion was having a drop size of 23.92±0.52 nm. It was free from nasal ciliotoxicity and stable for three months. Brain uptake of riluzole post intranasal administration of riluzole loaded nanoemulsion was significantly (P Conclusion This study indicates that nanoemulsion of riluzole for intranasal administration could be a promising approach for the treatment of ALS to minimize the…

Overview

Integrity signals

Registry

Crossref · 10.2174/1567201813666151202195729

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 59

Metadata

Authors
H. Parikh, R., & J. Patel, R.
Venue
Current Drug Delivery
Published
2016-10-18
Volume
13
Issue
7
Pages
1130-1143
ISSN
1567-2018 (ISSN-L)
OpenAlex
W2395640980
Cited by
56
References
0
Citations by year
2026: 5 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 1
FWCI
1.71
Type
journal article
Language
en
Open access
closed
Locations
  • Current Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
riluzole, nanoemulsions, intranasal drug delivery, amyotrophic lateral sclerosis, brain bioavailability, blood-brain barrier, P-glycoprotein, pharmacokinetics, brain uptake, oil-in-water emulsions, Tween 80
MeSH terms
Administration, Intranasal, Animals, Biological Availability, Brain, Chemistry, Pharmaceutical, Drug Stability, Emulsions, Lipids, Nasal Mucosa, Polymers, Solubility, Surface-Active Agents, Viscosity, Rats, Wistar, Neuroprotective Agents, Riluzole, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. https://app.cochat.ai/papers/10.2174/1567201813666151202195729
The paper
H. Parikh, R., & J. Patel, R. (2016). Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. Current Drug Delivery. https://doi.org/10.2174/1567201813666151202195729

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.